NASDAQ·Retail-Drug Stores and Proprietary Stores

111, Inc.

111, Inc. (ticker: YI) is an NASDAQ-listed retail-drug stores and proprietary stores company. DredgeCap's structured extraction of YI's SEC filings surfaces 2 active risk signals, including 1 auditor-change signal, and 1 late-filing signal. YI reported $1.80B in revenue and an untagged net result for the period ending 2025-12-31, with operating cash flow of $17.04M. Cash and equivalents stood at $73.07M (up 15.4% year-over-year). Total assets of $314.63M exceed total liabilities of $283.97M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

YI Cash Runway

Months-of-runway analysis for YI, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on YI

Share-count dilution →

Dilution is the natural counterpart to runway burn.

Going-concern history →

Auditor + management language across filings.